1-8 of 8
Elke Pogge von Strandmann, PHD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study with the Bispecific Anti-CD30 × Anti-CD16A Antibody Construct AFM13 in Patients with Relapsed or Refractory Hodgkin Lymphoma,

Achim Rothe, MD, Anas Younes, MD, Katrin S. Reiners, PhD, Markus Dietlein, MD, Dennis A. Eichenauer, MD, Joerg Kessler, Max S. Topp, MD, Horst Hummel, MD, Miroslav Ravic, MD, PhD, Christian Hucke, PhD, Elke Pogge von Strandmann, PhD, Andreas Engert, MD
Journal: Blood
Blood (2011) 118 (21): 3709.
https://doi.org/10.1182/blood.V118.21.3709.3709
Published: 2011
Journal Articles

NK Cells in Hodgkin Lymphoma Are Impaired but Can Be Activated

Joerg Kessler, Katrin S. Reiners, PhD, Maike Sauer, Andreas Engert, MD, Elke Pogge von Strandmann, PhD
Journal: Blood
Blood (2011) 118 (21): 2182.
https://doi.org/10.1182/blood.V118.21.2182.2182
Published: 2011
Journal Articles

A Bispecific Protein Targeting the NKG2D Receptor on Natural Killer Cells: In Vitro and In Vivo activity of ULBP2-CEA

Marie Madlener, Achim Rothe, MD, Ron Jachimowicz, Katrin S. Reiners, PhD, Sampurna Chatterjee, Roland Ullrich, MD, Paul Yazaki, PhD, Andreas Engert, MD, Elke Pogge von Strandmann, PhD
Journal: Blood
Blood (2010) 116 (21): 2095.
https://doi.org/10.1182/blood.V116.21.2095.2095
Published: 2010
Journal Articles

Prenylation Inhibitors as Potential Therapeutic Drugs in Hodgkin Lymphoma.

Bastian von Tresckow, MD, Peer Langendorf, Elke Pogge von Strandmann, PhD, Stefanie Sasse, MD, Samir Tawadros, Andreas Engert, MD, Hinrich P. Hansen, PhD
Journal: Blood
Blood (2006) 108 (11): 2513.
https://doi.org/10.1182/blood.V108.11.2513.2513
Published: 2006
Journal Articles

Mistargeting of Normal Cells in Anti-CD30 Immunotherapy of Lymphoma Cells Is Blocked by Selective Metalloproteinase Inhibitor.

Vijaya L. Simhadri, Elke Pogge von Strandmann, PhD, Dennis A. Eichenhauer, Andreas Ludwig, PhD, Katrin S. Reiners, PhD, Andreas Engert, PhD, Hinrich P. Hansen, PhD
Journal: Blood
Blood (2006) 108 (11): 2518.
https://doi.org/10.1182/blood.V108.11.2518.2518
Published: 2006
Journal Articles

Selection of Human Anti-CD22 scFvs from an Acute Lymphocytic Leukemia Related scFv Library with Ribosome Display.

Achim Rothe, MD, Ralf J. Hosse, PHD, Anne Nathanielsz, RA, Frank Oberhaeuser, RA, Elke Pogge von Strandmann, PHD, Andreas Engert, MD, Peter J. Hudson, PHD, Barbara E. Power
Journal: Blood
Blood (2006) 108 (11): 4527.
https://doi.org/10.1182/blood.V108.11.4527.4527
Published: 2006
Journal Articles

Tumor Cell-Derived HLA-B-Associated Transkript 3 (BAT3) Is a Ligand for NKp30 and Activates NK Cells.

Elke Pogge von Strandmann, PhD, Venkateswara R. Simhadri, Bastian von Tresckow, MD, Stefanie Sasse, MD, Katrin S. Reiners, PhD, Hinrich P. Hansen, PhD, Achim Rothe, MD, Peter Borchmann, MD, Peter J. McKinnon, PhD, Michael Hallek, Andreas Engert
Journal: Blood
Blood (2006) 108 (11): 643.
https://doi.org/10.1182/blood.V108.11.643.643
Published: 2006
Journal Articles

Engaging the NKG2D Receptor with a Novel Bispecific Protein (ULBP2-antiCD138) Activates NK Cells and Has Potent Antitumor Activity Against Human Multiple Myeloma.

Elke Pogge von Strandmann, PhD, Michael Hallek, MD, Andreas Engert, MD
Journal: Blood
Blood (2005) 106 (11): 5157.
https://doi.org/10.1182/blood.V106.11.5157.5157
Published: 2005